RESUMEN
Karyotype analysis can provide clues to significant genes involved in the genesis and growth of pancreas cancer. The genome of pancreas cancer is complex, and G-band analysis cannot resolve many of the karyotypic abnormalities seen. We studied the karyotypes of 15 recently established cell lines using molecular cytogenetic tools. Comparative genomic hybridization (CGH) analysis of all 15 lines identified genomic gains of 3q, 8q, 11q, 17q, and chromosome 20 in nine or more cell lines. CGH confirmed frequent loss of chromosome 18, 17p, 6q, and 8p. 14/15 cell lines demonstrated loss of chromosome 18q, either by loss of a copy of chromosome 18 (n = 5), all of 18q (n = 7) or portions of 18q (n = 2). Multicolor FISH (Spectral Karyotyping, or SKY) of 11 lines identified many complex structural chromosomal aberrations. 93 structurally abnormal chromosomes were evaluated, for which SKY added new information to 67. Several potentially site-specific recurrent rearrangements were observed. Chromosome region 18q11.2 was recurrently involved in nine cell lines, including formation of derivative chromosomes 18 from a t(18;22) (three cell lines), t(17;18) (two cell lines), and t(12;18), t(15;18), t(18;20), and ins(6;18) (one cell line each). To further define the breakpoints involved on chromosome 18, YACs from the 18q11.2 region, spanning approximately 8 Mb, were used to perform targeted FISH analyses of these lines. We found significant heterogeneity in the breakpoints despite their G-band similarity, including multiple independent regions of loss proximal to the already identified loss of DPC4 at 18q21.
Asunto(s)
Adenocarcinoma/genética , Aberraciones Cromosómicas , Neoplasias Pancreáticas/genética , Adenocarcinoma/patología , Línea Celular Tumoral , Bandeo Cromosómico , Cromosomas Humanos Par 18 , Cromosomas Humanos Par 8 , Humanos , Hibridación Fluorescente in Situ , Cariotipificación , Metafase , Hibridación de Ácido Nucleico , Neoplasias Pancreáticas/patologíaRESUMEN
Arsenic is effective in the treatment of acute promyelocytic leukemia. Paradoxically, it is also carcinogenic. In the process of elucidating a mechanism of arsenic resistance in a leukemia cell line, NB4, we discovered that arsenic exposure causes chromosomal abnormalities, with a preponderance of end-to-end fusions. These chromosomal end fusions suggested that telomerase activity may be inhibited by arsenic. We found that arsenic inhibits transcription of the hTERT gene, which encodes the reverse transcriptase subunit of human telomerase. This effect may in part be explained by decreased c-Myc and Sp1 transcription factor activities. Decreased telomerase activity leads to chromosomal end lesions, which promote either genomic instability and carcinogenesis or cancer cell death. These phenomena may explain the seemingly paradoxical carcinogenic and antitumor effects of arsenic.
Asunto(s)
Arsénico/farmacología , Regulación Enzimológica de la Expresión Génica/efectos de los fármacos , Telomerasa/genética , Transcripción Genética/efectos de los fármacos , Células 3T3 , Animales , Secuencia de Bases , Cromosomas Humanos , ADN/metabolismo , Cartilla de ADN , Proteínas de Unión al ADN , Humanos , Ratones , Factor de Transcripción Sp1/antagonistas & inhibidores , Factor de Transcripción Sp1/metabolismo , Células Tumorales CultivadasRESUMEN
We have identified a novel c-Myc-responsive gene, named JPO1, by representational difference analysis. JPO1 responds to two inducible c-Myc systems and behaves as a direct c-Myc target gene. JPO1 mRNA expression is readily detectable in the thymus, small intestine, and colon, whereas expression is relatively low in spleen, bone marrow, and peripheral leukocytes. We cloned a full-length JPO1 cDNA that encodes a 47-kDa nuclear protein. To determine the role of JPO1 in Myc-mediated cellular phenotypes, stable Rat1a fibroblasts overexpressing JPO1 were tested and compared with transformed Rat1a-Myc cells. Although JPO1 has a diminished transforming activity as compared with c-Myc, JPO1 complements a transformation-defective Myc Box II mutant in the Rat1a transformation assay. This complementation provides evidence for a genetic link between c-Myc and JPO1. Similar to c-Myc, JPO1 overexpression enhances the clonogenicity of CB33 human lymphoblastoid cells in methylcellulose assays. These observations suggest that JPO1 participates in c-Myc-mediated transformation, supporting an emerging concept that c-Myc target genes constitute nodal points in a network of pathways that lead from c-Myc to various Myc-related phenotypes and ultimately to tumorigenesis.
Asunto(s)
Transformación Celular Neoplásica/genética , Genes myc , Proteínas Nucleares/genética , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Células COS , Mapeo Cromosómico , Cromosomas Humanos Par 2 , Clonación Molecular , ADN Complementario , Prueba de Complementación Genética , Humanos , Datos de Secuencia Molecular , Proteínas Nucleares/química , Proteínas Nucleares/fisiología , RatasRESUMEN
Sodium phenylbutyrate (PB) is an aromatic fatty acid with cytostatic and differentiating activity against malignant myeloid cells (ID(50), 1-2 mM). Higher doses induce apoptosis. Patients with myelodysplasia (n = 11) and acute myeloid leukemia (n = 16) were treated with PB as a 7-day continuous infusion repeated every 28 days in a Phase I dose escalation study. The maximum tolerated dose was 375 mg/kg/day; higher doses led to dose-limiting reversible neurocortical toxicity. At the maximum tolerated dose, PB was extremely well tolerated, with no significant toxicities; median steady-state plasma concentration at this dose was 0.29 +/- 0.16 mM. Although no patients achieved complete or partial remission, four patients achieved hematological improvement (neutrophils in three, platelet transfusion-independence in one). Other patients developed transient increases in neutrophils or platelets and decrements in circulating blasts. Monitoring of the percentage of clonal cells using centromere fluorescence in situ hybridization over the course of PB administration showed that hematopoiesis remained clonal. Hematological response was often associated with increases in both colony-forming units-granulocyte-macrophage and leukemic colony-forming units. PB administration was also associated with increases in fetal erythrocytes. These data document the safety of continuous infusion PB and provide preliminary evidence of clinical activity in patients with myeloid malignancies.
Asunto(s)
Leucemia Mieloide/tratamiento farmacológico , Síndromes Mielodisplásicos/tratamiento farmacológico , Fenilbutiratos/uso terapéutico , Enfermedad Aguda , Anciano , Anciano de 80 o más Años , Alopecia/inducido químicamente , Antígenos CD34/análisis , Apoptosis/efectos de los fármacos , Ciclo Celular/efectos de los fármacos , Células Clonales , Diarrea/inducido químicamente , Relación Dosis-Respuesta a Droga , Hemoglobina Fetal/efectos de los fármacos , Hemoglobina Fetal/metabolismo , Citometría de Flujo , Hemorragia/inducido químicamente , Humanos , Persona de Mediana Edad , Mucosa Bucal/efectos de los fármacos , Mucosa Bucal/patología , Síndromes Mielodisplásicos/inmunología , Náusea/inducido químicamente , Fenilbutiratos/efectos adversos , Fenilbutiratos/farmacocinética , Estomatitis/inducido químicamente , Resultado del Tratamiento , Vómitos/inducido químicamenteRESUMEN
Sickle cell anemia (SCA) is an inherited disorder of beta-globin, resulting in red blood cell rigidity, anemia, painful crises, organ infarctions, and reduced life expectancy. Allogeneic blood or marrow transplantation (BMT) can cure SCA but is associated with an 8% to 10% mortality rate, primarily from complications of marrow-ablative conditioning. Transplantation of allogeneic marrow after less intensive conditioning reduces toxicity but may result in stable mixed hematopoietic chimerism. The few SCA patients who inadvertently developed mixed chimerism after BMT remain symptom free, suggesting that mixed chimerism can reduce disease-related morbidity. However, because the effects of various levels of mixed chimerism on organ pathology have not been characterized, this study examined the histologic effects of an increasing percentage of normal donor hematopoiesis in a mouse model of BMT for SCA. In lethally irradiated normal mice that were reconstituted with varying ratios of T-cell-depleted marrow from normal and transgenic "sickle cell" mice, normal myeloid chimerism in excess of 25% was associated with more than 90% normal hemoglobin (Hb). However, 70% normal myeloid chimerism was required to reverse the anemia. Organ pathology, including liver infarction, was present in mice with sickle Hb (HbS) levels as low as 16.8% (19.6% normal myeloid chimerism). Histologic abnormalities increased in severity up to 80% HbS, but were less severe in mice with more than 80% HbS than in those with 40% to 80% HbS. Therefore, stable mixed chimerism resulting from nonmyeloablative BMT may reduce the morbidity from SCA, but prevention of all disease complications may require minimizing the fraction of circulating sickle red cells. (Blood. 2001;97:3960-3965)
Asunto(s)
Anemia de Células Falciformes/terapia , Trasplante de Médula Ósea , Hematopoyesis , Quimera por Trasplante , Anemia de Células Falciformes/sangre , Anemia de Células Falciformes/patología , Animales , Femenino , Hemoglobina Falciforme/metabolismo , Recuento de Leucocitos , Modelos Lineales , Hígado/patología , Masculino , Ratones , Ratones Transgénicos , Modelos Animales , Recuento de Reticulocitos , Bazo/patologíaRESUMEN
A prenatal tumor located in the lumbar paravertebral area was discovered during a routine ultrasound examination at 32 weeks of pregnancy and surgically removed at 4 months of life. The histopathological diagnosis was first suggested to be an infantile desmoid fibromatosis. The tumor karyotype showed a three-way translocation involving both chromosomes 2 and a chromosome 11, t(2;11;2)(p23;p15;q31). Fluorescence in situ hybridization with a probe flanking the ALK gene at 2p23 demonstrated a rearrangement, as previously described in inflammatory myofibroblastic tumors (IMTs). In light of the genetic analysis, the histopathological diagnosis was revised to IMT, although inflammatory cells were scarce. IMTs are pseudosarcomatous inflammatory lesions that primarily occur in the soft tissue and viscera of children and young adults. Our report describes for the first time the occurrence of IMT during prenatal life. The ALK rearrangement may represent the molecular definition of a subgroup of mesenchymal tumors, not always with complete morphological features of IMT, similar to the model of EWS rearrangement in the Ewing sarcoma family of tumors.
Asunto(s)
Cromosomas Humanos Par 11/genética , Cromosomas Humanos Par 2/genética , Sondas de ADN , Enfermedades Fetales/genética , Granuloma de Células Plasmáticas/clasificación , Granuloma de Células Plasmáticas/genética , Proteínas Tirosina Quinasas/genética , Translocación Genética/genética , Adulto , Quinasa de Linfoma Anaplásico , Pintura Cromosómica , Femenino , Enfermedades Fetales/clasificación , Enfermedades Fetales/diagnóstico por imagen , Enfermedades Fetales/patología , Granuloma de Células Plasmáticas/diagnóstico por imagen , Granuloma de Células Plasmáticas/patología , Humanos , Hibridación Fluorescente in Situ , Cariotipificación , Embarazo , Proteínas Tirosina Quinasas Receptoras , Ultrasonografía PrenatalRESUMEN
A primary effusion lymphoma (PEL) cell line, JSC-1, that yields highly infectious Kaposi's sarcoma herpesvirus (KSHV) supernatants was established from the ascitic fluid of a human immunodeficiency virus-positive patient. Flow cytometry showed strong expression of CD45 and lambda light-chain restriction. Southern blot hybridization showed immunoglobulin heavy-chain gene rearrangements in the tumor and the resultant cell line consistent with B-cell lineage. Expression of viral genes was assessed by reverse transcription-PCR and immunohistochemistry. Only latent Epstein-Barr virus (EBV) gene expression was detected, and this was at a low level. In contrast, lytic and latent KSHV gene expression were detected. Tetradecanoyl phorbol acetate and butyrate upregulated KSHV lytic expression, but not EBV lytic expression. Viral supernatant from JSC-1 was much more efficient at infecting primary human dermal microvascular endothelial cells (DMVECs) with KSHV than supernatants from BC-3 or BCP-1 PEL cell lines. Quantitation of viral yields produced by the PEL lines showed at least 2 orders of magnitude more DNase I-resistant KSHV DNA in the JSC-1 supernatant compared to BC-3 or BCP-1 supernatants. KSHV infection in DMVECs was associated with a change from a cobblestone to a spindle shape, LANA expression, and an increased number of mitoses.
Asunto(s)
Líquido Ascítico/citología , Herpesvirus Humano 8/aislamiento & purificación , Linfoma Relacionado con SIDA/virología , Células Tumorales Cultivadas , Líquido Ascítico/virología , Endotelio Vascular/citología , Endotelio Vascular/virología , Técnica del Anticuerpo Fluorescente , Herpesvirus Humano 4/genética , Herpesvirus Humano 4/aislamiento & purificación , Herpesvirus Humano 8/genética , Herpesvirus Humano 8/patogenicidad , Humanos , Inmunohistoquímica , Hibridación in Situ , Masculino , Persona de Mediana Edad , Piel/irrigación sanguínea , Virión/fisiologíaRESUMEN
Techniques based on fluorescence in situ hybridization (FISH) have bridged the gap between molecular genetics and conventional cytogenetics. Since its introduction in the late 1980s, advanced FISH-based methods have greatly enhanced the cytogenetic analysis of hematopoietic and solid tumors and are rapidly gaining ground in clinical cytogenetic diagnostics. As interest in FISH technologies has grown, it has inspired an era of new FISH-based technologies such as multiplex FISH, spectral karyotyping, and comparative genomic hybridization. In this review, the focus is on the impact of these technologies in the field of cancer genetics.
Asunto(s)
Hibridación Fluorescente in Situ/métodos , Neoplasias/genética , Aberraciones Cromosómicas/diagnóstico , Trastornos de los Cromosomas , Citogenética/tendencias , Humanos , Cariotipificación/métodosRESUMEN
Inflammatory myofibroblastic tumor (IMT) is a relatively rare soft tissue tumor. The reactive versus neoplastic pathogenesis of this tumor is unresolved. We found clonal chromosome aberrations involving 2p23 upon metaphase analysis of two IMTs. Fluorescence in situ hybridization with a probe flanking the ALK gene at 2p23 demonstrated rearrangement of the probe in both of these cases and in a third case, and immunohistochemistry revealed ALK expression in all three cases. 2p22-24 involvement has been reported previously in four additional cases of IMT. We suggest that chromosomal rearrangements involving 2p23 near or within ALK are recurrent alterations in IMT and that ALK may have a novel role outside its previously recognized realm of lymphoid neoplasms.
Asunto(s)
Cromosomas Humanos Par 2 , Neoplasias de Tejido Muscular/genética , Quinasa de Linfoma Anaplásico , Niño , Sondas de ADN , Femenino , Humanos , Inmunohistoquímica , Hibridación Fluorescente in Situ , Lactante , Cariotipificación , Masculino , Neoplasias de Tejido Muscular/metabolismo , Proteínas Tirosina Quinasas/biosíntesis , Proteínas Tirosina Quinasas ReceptorasRESUMEN
The difficulty of maintaining long-term prostate cell cultures has hindered the development of essential models for understanding prostate cancer. We report here the establishment of two 12S E1A transformed non-tumorigenic prostate epithelial cell strains, and their characterization. The two clonal cell strains, TP2 and TP4, proliferated for approximately 40 passages before senescence. Both exhibited a strong dependence on exogenous peptide growth factors and an immunophenotype characteristic of their prostate epithelial origin. Cytogenetic analysis revealed a consistent deletion on the q arm of chromosome 16 in TP2 with an otherwise normal karyotype. Band-specific microdissection generated region-specific probes from 16q23, which when used in fluorescence in situ hybridization (FISH) revealed that the region was deleted in 83% of metaphases analyzed. By cytogenetic analysis and FISH, the q arm of 16 was found deleted from the genome of TP4 in 60% of cells analyzed. Lost sequences on 16q-16q23 in particular--in prostate cancer have been observed by a variety of methods. Localization of common region of deletion has been determined from these studies to be distal to 16q23. Our findings suggest that 16q23 may be of major importance in the development of prostate cancer, and may harbor tumor suppressor elements.
Asunto(s)
Transformación Celular Viral/genética , Deleción Cromosómica , Cromosomas Humanos Par 16/genética , Células Epiteliales/citología , Células Epiteliales/metabolismo , Próstata/citología , Próstata/metabolismo , Proteínas E1A de Adenovirus/genética , Animales , Técnicas de Cultivo de Célula/métodos , Línea Celular Transformada , Células Epiteliales/virología , Humanos , Cariotipificación , Masculino , Ratones , Ratones Desnudos , Persona de Mediana EdadRESUMEN
We cloned JAK3, the most recently described member of the JAK family of intracellular tyrosine kinases, from normal human CD34+ RNA. JAK3 is involved in the signal transduction pathways of the IL-2, IL-4, IL7, IL-9, and IL-15 receptors by association with their common gamma-chain (gamma[c]). JAK3 is critical to lymphoid development, as recently established by the linking of mutations in JAK3 to a subgroup of patients with SCID and the generation of JAK3-null mice with severe disruptions in normal lymphocytic development. However, JAK3 expression is not restricted to the lymphocytic compartment of bone marrow but is found in a wide range of tissues of both hematopoietic and non-hematopoietic origin. Northern blot analysis indicates that JAK3 is also expressed in adult placenta, lung, liver, kidney, pancreas, spleen, thymus, ovary, and small intestine. RNAse protection assays and RT-PCR indicate that JAK3 is expressed in a variety of leukemic-derived hematopoietic cell lines with myeloid and/or lymphoid phenotypes. In normal human bone marrow, JAK3 is expressed in the CD34+/lineage- fraction, which is highly enriched in hematopoietic stem/progenitor cells. In addition, we found a splice variant of JAK3 which is formed by the splicing of JAK3 with exon II of the leydig insulin-like (LEY I-L) hormone. RT-PCR and RNAse protection assay analyses indicate that this variant (termed I-JAK3) is normally expressed in almost all hematopoietic and non-hematopoietic tissues shown to express JAK3. Using fluorescence in situ hybridization we have localized JAK3 to 19p12-13.1, the same region of chromosome 19 to which the LEY I-L hormone maps (19p12-13.2).
Asunto(s)
Mapeo Cromosómico , Cromosomas Humanos Par 19 , Proteínas Tirosina Quinasas/genética , Adulto , Secuencia de Aminoácidos , Animales , Antígenos CD34/análisis , Secuencia de Bases , Médula Ósea/inmunología , Células de la Médula Ósea , Células Clonales/inmunología , Expresión Génica , Variación Genética , Humanos , Hibridación Fluorescente in Situ , Janus Quinasa 3 , Masculino , Datos de Secuencia Molecular , Reacción en Cadena de la PolimerasaRESUMEN
We determined the chromosomal localization and partial genomic structure of the coding region of the human PPAR gamma gene (hPPAR gamma), a nuclear receptor important for adipocyte differentiation and function. Sequence analysis and long PCR of human genomic DNA with primers that span putative introns revealed that intron positions and sizes of hPPAR gamma are similar to those previously determined for the mouse PPAR gamma gene[13]. Fluorescent in situ hybridization localized hPPAR gamma to chromosome 3, band 3p25. Radiation hybrid mapping with two independent primer pairs was consistent with hPPAR gamma being within 1.5 Mb of marker D3S1263 on 3p25-p24.2. These sequences of the intron/exon junctions of the 6 coding exons shared by hPPAR gamma 1 and hPPAR gamma 2 will facilitate screening for possible mutations. Furthermore, D3S1263 is a suitable polymorphic marker for linkage analysis to evaluate PPAR gamma's potential contribution to genetic susceptibility to obesity, lipoatrophy, insulin resistance, and diabetes.
Asunto(s)
Mapeo Cromosómico , Cromosomas Humanos Par 3/genética , Receptores Citoplasmáticos y Nucleares/genética , Factores de Transcripción/genética , Tejido Adiposo/metabolismo , Animales , Secuencia de Bases , Bandeo Cromosómico , Clonación Molecular , ADN/genética , Cartilla de ADN/genética , Exones , Ligamiento Genético , Marcadores Genéticos , Humanos , Intrones , Ratones , Sondas de Oligonucleótidos/genética , Reacción en Cadena de la Polimerasa , Polimorfismo GenéticoRESUMEN
Previously, we identified a novel human cytochrome P450 cDNA that is inducible by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and represents the first member of a new subfamily designated cytochrome P4501B1 (CYP1B1; Sutter, T. R., Tang, Y. M., Hayes, C. L., Wo, Y. P., Jabs, E. W., Li, X., Yin, H., Cody, C. W., and Greenlee, W. F. (1994) J. Biol. Chem. 269, 13092-13099). Here, we report on the isolation and initial characterization of the CYP1B1 gene. The CYP1B1 gene maps to human chromosome 2 at 2p21-22 and contains three exons and two introns. The putative open reading frame starts in the second exon and is 1629 base pairs in length. Southern analysis using DNA probes directed to each of the three exons confirmed that CYP1B1 is a single copy gene. Human CYP1B1 differs from its two most closely related members of the cytochrome P450 superfamily, CYP1A1 and CYP1A2, in the number of exons (3 versus 7) and chromosome location (2 versus 15). A single transcription initiation site was identified by primer extension analysis and S1 nuclease mapping. Based on nucleotide sequence analysis, the CYP1B1 gene lacks a consensus TATA box in the promoter region and contains nine TCDD-responsive enhancer core binding motifs (5'-GCGTG-3') located within a 2.5-kilobase pair genomic fragment 5'-ward of the transcription initiation start site. Deletion analysis of chloramphenicol acetyltransferase reporter gene constructs containing 5' CYP1B1 genomic fragments indicates that a region from -1022 to -835 containing three of the nine core binding motifs contributes to the TCDD-inducible expression of CYP1B1.
Asunto(s)
Hidrocarburo de Aril Hidroxilasas , Sistema Enzimático del Citocromo P-450/genética , Secuencia de Bases , Southern Blotting , Mapeo Cromosómico , Citocromo P-450 CYP1B1 , Genes Reporteros , Humanos , Datos de Secuencia Molecular , Eliminación de Secuencia , Endonucleasas Específicas del ADN y ARN con un Solo Filamento/metabolismoRESUMEN
The classical definition of lymphohematopoietic stem cells (LHSC), the most primitive progenitors of all blood cells, requires that they have the capacity for self-renewal and for the long-term production of all blood cell lineages. However, other characteristics of LHSC have been debated. Our previous data suggested that mouse LHSC are very slowly proliferating cells that generate delayed multilineage engraftment, while "radioprotection" (rapid engraftment that will prevent early death from radiation-induced marrow aplasia) results from more committed progenitors. Alternatively, some groups have reported that mouse LHSC are responsible for both radioprotection and long-term repopulation of all blood cell lineages. A possible explanation for this difference is that cells with the capacity for long-term production of all blood cell lineages are biologically heterogeneous. We now show that 10 LHSC can generate all blood cell lineages for the lifetime of the animal. However, these cells lacked radioprotection and spleen colony-forming activity. LHSC were identified and isolated by their small size, their lack of expression of antigens characteristic of mature blood cell lineages, and their high expression of aldehyde dehydrogenase. In addition, these cells were found to express undetectable or low levels of many antigens presumed to mark LHSC, including Thy-1, Ly-6A/E (Sca-1), c-kit, and CD34. There appears to be at least two classes of LHSC with the capacity for long-term production of all blood cell lineages: one that generates both radioprotection and long-term engraftment and one that produces delayed but durable engraftment. Our data suggest that this latter class may represent a very primitive class of LHSC.
Asunto(s)
Células de la Médula Ósea , Células Madre Hematopoyéticas/clasificación , Bazo/citología , Aldehído Deshidrogenasa/análisis , Animales , Antígenos Ly/análisis , Secuencia de Bases , Biomarcadores , Trasplante de Médula Ósea , Linaje de la Célula , Tamaño de la Célula , Ensayo de Unidades Formadoras de Colonias , Femenino , Células Madre Hematopoyéticas/citología , Células Madre Hematopoyéticas/fisiología , Inmunofenotipificación , Masculino , Proteínas de la Membrana/análisis , Ratones , Datos de Secuencia Molecular , Quimera por Radiación , Tolerancia a Radiación , Antígenos Thy-1/análisisRESUMEN
Hexokinase type II is highly overexpressed in many cancer cells, where it plays a pivotal role in the high glycolytic phenotype. Here we demonstrate by Southern blot analysis and fluorescence in situ hybridization (FISH) that in the rapidly growing rat AS-30D hepatoma cell line, enhanced hexokinase activity is associated with at least a 5-fold amplification of the type II gene relative to normal hepatocytes. This amplification is located chromosomally, extends to the whole gene, and most likely occurs at the site of the resident gene. No rearrangement of the gene could be detected. Therefore, overexpression of hexokinase type II in AS-30D hepatoma cells may be based, at least in part, on a stable gene amplification. This is the first report describing the amplification of a hexokinase gene in a tumor cell line expressing the high glycolytic phenotype.
Asunto(s)
Glucosa/metabolismo , Hexoquinasa/genética , Animales , ADN de Neoplasias/genética , Femenino , Regulación Enzimológica de la Expresión Génica , Regulación Neoplásica de la Expresión Génica , Hibridación Fluorescente in Situ , Polimorfismo de Longitud del Fragmento de Restricción , ARN Mensajero/genética , Ratas , Ratas Sprague-DawleyRESUMEN
Despite attempts by several laboratories to identify consistent chromosome abnormalities in cancer of the prostate, relatively few clonal changes have been found. We compared analysis of metaphases from uncultured specimens of primary prostate cancer (direct preparations) with those obtained from short-term culture using various media. While the number of metaphases in uncultured specimens was low, and chromosome morphology fair to poor, structural chromosome changes could be identified as clonal in 5 of 14 specimens (36%). In contrast, while clonal abnormalities were found in 20 of 61 (33%) specimens analyzed after short-term culture, these abnormalities were predominantly numerical and simple structural changes. Two tumors metastatic to lymph nodes were studied using direct preparations; both were near tetraploid, with multiple structural abnormalities, including isochromosome 8q in both and del(8)(p21) in one. Cytogenetic analyses of metastatic prostate tumors have been very limited, and these data suggest that formation of an i(8q) may be the mechanism by which loss of heterozygosity of 8p, reported frequently in molecular analyses, occurs. Our findings indicate that prostate cancers, like most solid tumors, do have clonal chromosome abnormalities that are frequently complex, but the method that reproducibly yields representative karyotypes from this particular tumor remains to be identified.
Asunto(s)
Aberraciones Cromosómicas/genética , Neoplasias de la Próstata/genética , Anciano , Células Cultivadas , Aberraciones Cromosómicas/epidemiología , Deleción Cromosómica , Trastornos de los Cromosomas , Humanos , Cariotipificación , Masculino , Persona de Mediana Edad , Neoplasias de la Próstata/patologíaRESUMEN
Degenerate PCR was employed to identify novel tyrosine kinase genes from an enriched population of human umbilical cord blood hematopoietic stem/progenitor cells. One novel tyrosine kinase gene, designated Tnk1, was cloned. The sequence of the complete Tnk1 coding region predicts a 72 kD protein. Comparison of Tnk1 to available sequences in protein databases reveals that it is most homologous to Ack, an intracellular tyrosine kinase which associates with the GTP-bound form of p21cdc42Hs. Like Ack, Tnk1 consists of an N-terminal kinase domain, a putative SH3 domain immediately C-terminal to the kinase domain, and a proline-rich C-terminal region. Analysis of Tnk1 mRNA expression demonstrates that Tnk1 is expressed in all cord blood, bone marrow and adult blood sub-populations, as well as in most of the leukemia cell lines examined (16 of 20). Hybridization to fetal multi-tissue Northern blots detected several different Tnk1 transcripts in all fetal tissues examined. In contrast, a single Tnk1 transcript was detected in only five of 16 adult tissues examined (prostate, testis, ovary, small intestine and colon). Fluorescence in situ hybridization (FISH) analysis of metaphase chromosomes localized the Tnk1 gene to the short arm of chromosome 17 (17p13.1), near the p53 locus. Thus, Tnk1 is a novel tyrosine kinase that may be involved in signalling pathways utilized broadly during fetal development, more selectively in adult tissues and in cell of the lymphohematopoietic system.
Asunto(s)
Cromosomas Humanos Par 17 , Sangre Fetal/citología , Proteínas Fetales/biosíntesis , Proteínas Fetales/genética , Células Madre Hematopoyéticas/enzimología , Proteínas Tirosina Quinasas/biosíntesis , Proteínas Tirosina Quinasas/genética , ADP-Ribosil Ciclasa , ADP-Ribosil Ciclasa 1 , Secuencia de Aminoácidos , Antígenos CD/sangre , Antígenos CD34/sangre , Antígenos de Diferenciación/sangre , Secuencia de Bases , Northern Blotting , Línea Celular , Mapeo Cromosómico , Cartilla de ADN , Femenino , Feto , Expresión Génica , Humanos , Hibridación Fluorescente in Situ , Cariotipificación , Leucemia , Glicoproteínas de Membrana , Datos de Secuencia Molecular , N-Glicosil Hidrolasas/sangre , Especificidad de Órganos , Reacción en Cadena de la Polimerasa , Embarazo , ARN Mensajero/análisis , ARN Mensajero/biosíntesis , Mapeo Restrictivo , Homología de Secuencia de Aminoácido , Células Tumorales CultivadasRESUMEN
The prostate-specific membrane antigen (PSM) was identified by the monoclonal antibody 7E11-C5.3, which was raised against the human prostatic carcinoma cell line LNCaP (3). The PSM antigen is expressed by normal, neoplastic, and metastatic prostatic tissues. The 2.65-kb cDNA encoding the 100-kDa PSM glycoprotein was cloned from LNCaP cells (4). Studies have shown that the expression of PSM is tissue-specific (5). In the present study monochromosomal somatic cell hybrids were used to localize the PSM gene to human chromosome 11. Using this information, initial mapping studies identified two potential PSM gene loci at 11p11.1-p13 and 11q14. Further high-stringency analysis using cosmid probes identified the 11q14 region as the location of the PSM gene.
Asunto(s)
Antígenos de Neoplasias/genética , Antígenos de Superficie/genética , Cromosomas Humanos Par 11 , Southern Blotting , Mapeo Cromosómico/métodos , Glutamato Carboxipeptidasa II , Humanos , Células Híbridas , Hibridación Fluorescente in Situ/métodos , MasculinoRESUMEN
Merkel cell carcinoma (MCC) is a primary cutaneous neoplasm most commonly involving older adults. The cell of origin is thought to be the Merkel cell, a cutaneous neurosecretory cell. However, other neuroectodermal tumors may present in the skin and may be difficult to distinguish from MCC, including peripheral neuroectodermal tumors (PNET) and metastatic small cell carcinoma. We examined a primary cutaneous tumor of an 18-year-old which was strongly positive for cytokeratin (CK), neuron-specific enolase (NSE), and 12E7, an antibody to the protein determined by the MIC2 gene. Electron microscopy showed paranuclear aggregates of filaments and no cytoplasmic processes. These findings were considered to be consistent with MCC. Cytogenetic analysis demonstrated 46,XX,der(1)t(1;3;22)(1qter-->pa34::3q28-->q11::22q 12--> qter),der(3)t(1;3)(3pter-->q11::1p35-->pter), der(22)t(3;22)(22pter-->q11::?3q29-->qter). This was confirmed by chromosome painting using probes for chromosomes 1, 3, and 22. Peripheral neuroectodermal tumors (PNETs) show a characteristic translocation involving the same breakpoint on chromosome 22 that was present in this tumor. PNETs can also be CK and NSE positive. The MIC2 gene codes for a surface glycoprotein that has been shown to be very strongly and reliably expressed in PNETs, but not in other small round blue cell tumors and not in small cell carcinoma of the lung. However, MIC2 expression has not been studied in MCC. We investigated the use of MIC2 analysis in the distinction of MCC from PNET. Five additional MCCs were stained with the monoclonal 12E7 antibody, and one additional tumor showed the strong membranous positivity reported in PNETs. Our data suggest that MIC2 analysis may be useful in differentiating between MCC and PNET. However, cases will remain for which the distinction is elusive and cytogenetic analysis may be helpful.